Ahmed Abdelhady Abozeid, PhD (he/him/his)

Clinical Pharmacology Director
Intellia

Disclosure(s): Intellia Therapeutics: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentation(s):

• Cell & Gene Therapies

  Sunday, November 10, 2024
  9:00 AM – 10:15 AM MST

• Quantitative Pharmacology Approach to Inform the Bench-to-Bed Translation of CRSPR-Based in-vivo Gene Editing Therapy across Multiple Development Phases

  Sunday, November 10, 2024
  9:50 AM – 10:15 AM MST